Cargando…
Characterization of STAT3 activation and expression in canine and human osteosarcoma
BACKGROUND: Dysregulation of signal transducer and activator of transcription 3 (STAT3) has been implicated as a key participant in tumor cell survival, proliferation, and metastasis and is often correlated with a more malignant tumor phenotype. STAT3 phosphorylation has been demonstrated in a subse...
Autores principales: | Fossey, Stacey L, Liao, Albert T, McCleese, Jennifer K, Bear, Misty D, Lin, Jiayuh, Li, Pui-Kai, Kisseberth, William C, London, Cheryl A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666757/ https://www.ncbi.nlm.nih.gov/pubmed/19284568 http://dx.doi.org/10.1186/1471-2407-9-81 |
Ejemplares similares
-
Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011) -
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
por: Fossey, Stacey L, et al.
Publicado: (2011) -
Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
por: Couto, Jason I, et al.
Publicado: (2012) -
Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer
por: London, Cheryl A., et al.
Publicado: (2011) -
Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma
por: Brown, Megan E., et al.
Publicado: (2015)